Relugolix: A Review in Advanced Prostate Cancer | Targeted Oncology
NG131 evidence review B
Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment | American Society of Clinical Oncology Educational Book
Prostate Cancer - TREATMENT - Uroweb
Prostate Cancer Treatment (PDQ®) - NCI
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions | American Society of Clinical Oncology Educational Book
Novel Targets and Treatment Developments in Metastatic Hormone Sensitive Prostate Cancer
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design -
How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope | JACC: CardioOncology
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer | Published in International Journal of Cancer Care and Delivery
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial - ScienceDirect
Current Oncology | Free Full-Text | Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 5 (2019)
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
Full article: Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design - ScienceDirect
Prostate Cancer Treatment & Management: Approach Considerations, Localized Prostate Cancer, Management of Advanced and Metastatic Disease
A Clinically-Achievable Injectable and Sprayable in Situ Lyotropic Liquid Crystalline Platform in Treating Hormone-Sensitive and Castration-Resistant Prostate Cancer | ACS Nano
Salvage therapy for prostate cancer after radical prostatectomy | Nature Reviews Urology
